The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.
inhibitors including Bristol-Myers Squibb’s Opdivo (nivolumab) and Merck KGaA/Pfizer’s Bavencio (avelumab).
Merck Sharp &Dohme (MSD), the company that markets Keytruda, and Bristol-Myers Squibb (BMS), the company that markets Opdivo, approached development of their respective products in this area with starkly contrasting
Although not stated in the news announcement, that could include BMS’ checkpoint inhibitor Opdivo (nivolumab), which is indicated for use across a number of cancer types.
The CHMP also noted the withdrawal of Bristol-Myers Squibb’s Opdivo (nivolumab) and Yervoy (iplimumab) application, which was seeking marketing authorisation in first-line metastatic non-small cell lung cancer.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...